Roche breast cancer drug gets FDA priority review
(Reuters) - Health regulators granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. (Source: Reuters: Health)
Doctor: Teens' mystery illness not a hoax
More at N.Y. school diagnosed with mysterious tics; Neurologist says they suffer conversion disorder - real symptoms without a cause (Source: Health News: CBSNews.com)